Clinical Trials Logo

Mental Disorders clinical trials

View clinical trials related to Mental Disorders.

Filter by:

NCT ID: NCT05618990 Recruiting - Stroke Clinical Trials

OPTIMIZATION of ADVANCED MR SEQUENCES

OPT-IRM
Start date: November 5, 2019
Phase:
Study type: Observational

This monocentric methodological study aims at optimizing advanced MR sequences for image quality (reduced artefacts, signal to noise ratio, acquisition time, stability of quantitative measurements) on a new MR unit dedicated to research in clinical and cognitive neuroscience.

NCT ID: NCT05617898 Recruiting - Psychosis Clinical Trials

Determining the Role of Social Reward Learning in Social Anhedonia

SAMI
Start date: June 14, 2023
Phase: N/A
Study type: Interventional

This is a clinical trial study that aims to evaluate the specificity of the relationship between reduced sensitivity to social reward and social anhedonia at both behavioral and neural levels. Individuals who recently experienced their first-episode psychosis will be recruited. Participants will be randomized 1:1 to motivational interviewing or a time- and format-matched control probe. At pre- and post-probe, participants will perform two social reward learning tasks in the scanner. With this design feature, we will examine the relationship between sensitivity to social reward and reduced subjective experience of social pleasure at both the behavioral and neural levels.

NCT ID: NCT05617781 Completed - Clinical trials for Post-traumatic Stress Disorder

Empathy in Post-traumatic Stress Disorder in Comparaison to a Control Population

Start date: July 27, 2023
Phase:
Study type: Observational

It has been shown in the literature that the symptoms of post-traumatic stress disorder influence the quality of life of patients, in particular through the cognitive alterations they can cause. Social cognition is also itself impacted. It refers to the perception, interpretation and processing of information relating to the social environment and relationships. It is affected by the symptomatology of PTSD both in terms of the response to emotional stimuli, the perception of self and others, and the quality of intimate relationships. These elements lead to reflection on the origin of these alterations, in particular the impact of PTSD on the patient's empathy capacity, defined as the recognition and understanding of the feelings and emotions of another individual. This parameter is also little studied in the literature, only a study dating from 2010 finds a correlation between PTSD and empathy. It is in this context that the realization of a new study studying the capacity for empathy of patients with PTSD in comparison with a control group with a larger and more representative population was envisaged. The primary outcome of this study is to analyze the post-traumatic stress disorder's repercussions on empathy by passing the Interpersonal Reactivity Index (IRI) on patients in comparison with a control group. The first hypothesis is a lower total score but a higher personal distress sub-score in the PTSD population. The secondary outcomes are to describe the cofactors that can influence empathy in association or not with post-traumatic stress disorder: sociodemographic data (age, sex, education level…), traumatic event type determined through the "Inventory of Traumatogenic Events", human intervention, duration and severity of the disorder (evaluated by the Impact of Events Scale) … The number of subjects required was calculated at 19 patients and 19 controls.

NCT ID: NCT05615324 Recruiting - Parenting Clinical Trials

SAFIR Family Talk - Investigating the Effect of The Family Talk Intervention

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the effect of the Family Talk Preventive Intervention compared to service as usual for families where a parent has mental illness. Participants are the parent with a mental illness receiving treatment from a secondary mental health service within the last two years from inclusion, their youngest child aged 7-17 years and the other parent of this child. The main questions it aims to answer are: Is Family Talk superior to service as usual regarding improving? - The child's level of functioning - The parent's sense of competence - Family functioning Participants will undergo interviews and fill out questionnaires. Half will be randomized to Family Talk and receive a manualized, family-based intervention of approximately 8 conversations with a trained, Family Talk interventionist. The other half will be randomized to service as usual which is normally two conversations with a professional in the mental health sector. The researchers will compare the two groups on child's level of functioning, parental sense of competence and family functioning.

NCT ID: NCT05611372 Not yet recruiting - Parkinson Disease Clinical Trials

Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease

Start date: January 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

To investigate whether a year of rasagiline may reduce the progression from idiopathic REM sleep behavior disorder (RBD) to Parkinson's disease (PD).

NCT ID: NCT05607875 Completed - Mental Disorders Clinical Trials

The Grow to Recovery Train-the-Trainer Program

Start date: November 2, 2022
Phase: N/A
Study type: Interventional

Recovery-oriented services are becoming popular in the mental health field. However, recovery-oriented services are still in the beginning stages in Taiwan. Many professionals do not know how to implement recovery-oriented services. More effort should be made to improve mental health services in Taiwan. Hence, the aim of this study is to examine the effectiveness of the Grow to Recovery Train-the-Trainer program.

NCT ID: NCT05602870 Not yet recruiting - Liver Fibrosis Clinical Trials

Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit

HEPSY
Start date: December 1, 2022
Phase: N/A
Study type: Interventional

Scares data exists concerning the prevalence of chronic liver diseases in people with psychiatric disorders. There are still many barriers to screening and linkage to care for patients having somatic illness. Moreover follow-up of these patients may be difficult because of poor access to care, sometimes marginalization, and insufficient compliance with health programs. The aim of this study is to asses acceptability of of advanced chronic liver disease screening by transient elstography (Fibroscan ®) in patients hospitalised in a psychiatric unit.

NCT ID: NCT05600205 Not yet recruiting - Lifestyle Clinical Trials

Evaluation of Combined Support for the Ambulatory Lifestyle Intervention

GOAL!
Start date: November 1, 2022
Phase: N/A
Study type: Interventional

For people with a severe mental illness (SMI) there is no appropriate lifestyle intervention in ambulatory care, while they would benefit greatly from it. With SMI is meant mainly psychotic-, bipolar- and severe mood or anxiety disorders that require long-term care and counseling. People with SMI have a one-and-a-half to two times higher risk of heart disease, diabetes, and reduced mental health than the general population. This combination contributes to up to 15 years shorter life expectancy and reduced quality of life. Lifestyle plays an important role in this. Combined Support for the Ambulatory Lifestyle Intervention (GOAL!) is a multidisciplinary lifestyle support intervention where people with SMI are supervised for a longer period of time by qualified professionals, with attention to individual wishes and perceived challenges. Although the newly introduced so-called combined lifestyle interventions, that were recently introduced on a national level, follow this line of thinking, people with SMI may not benefit sufficiently from this offer. From the common challenge and need to create improved support, GGz Centraal in cooperation with the municipalities in the North Veluwe and local partners developed GOAL! and will pilot its use. This is done in cooperation with health insurers within the framework of an Innovation Policy Rule of the Dutch Healthcare Authority. The aim of this study is to follow this innovation and evaluate the implementation and effectiveness of GOAL!.

NCT ID: NCT05597579 Recruiting - Clinical trials for Cognitive Impairment

Cognitive Impairments in Psychotic Disorders

Start date: February 12, 2020
Phase:
Study type: Observational

Patients with Psychotic disorders (Schizophrenia, Bipolar disorder and Schizoaffective disorder) often suffer from significant cognitive impairments, however how these develop and change over time before and after the first psychotic break is unclear. While there are data by several groups, showing that many future patients have significant cognitive impairments years before the onset of psychosis, many future patients seem to be doing well before the manifestation of psychosis, and decline steeply in functioning after their first psychotic episode. Hence the timing of the onset of cognitive impairment in patients with psychotic disorders requires further exploration. The current study will investigate the timing of cognitive impairment by using IQ tests before and after the first psychotic break

NCT ID: NCT05593276 Completed - Depression Clinical Trials

The Preliminary Effects of Empower@Home

Start date: January 5, 2023
Phase: N/A
Study type: Interventional

This randomized pilot trial uses a waitlist control parallel design of a novel internet-based cognitive behavioral therapy program for older adults with elevated depressive symptoms. This study will enroll approximately 35 older adults per group throughout Michigan. The intervention will take approximately ten weeks to complete. Participants will have lower levels of depression after completing the intervention than before enrollment. Participants will be able to use the internet-based platform with minimal support.